日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study.

希腊非转移性非小细胞肺癌患者的真实世界治疗模式:'EVIDENCE' 研究

Mountzios Giannis, Lampaki Sofia, Linardou Helena, Georgoulias Vassilis, Mavroudis Dimitrios, Anevlavis Stavros, Charpidou Andriani, Lykka Maria, Spyratos Dionysis, Sarris Evangelos G, Somarakis Alvertos, Papista Christina, Glentis Alexandros, Nikolaou Aristeidis, Paparepa Zoe, Papageorgiou Foteini, Syrigos Konstantinos N

Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis

反应性血管扩张可预测原发性系统性轻链淀粉样变性的死亡率

Kimon Stamatelopoulos, Georgios Georgiopoulos, Fani Athanasouli, Panagiota-Efstathia Nikolaou, Marita Lykka, Maria Roussou, Maria Gavriatopoulou, Aggeliki Laina, Georgia Trakada, Marietta Charakida, Dimitris Delialis, Ioannis Petropoulos, Constantinos Pamboukas, Efstathios Manios, Marina Karakitsou,

Treating ALK-positive non-small cell lung cancer

治疗ALK阳性非小细胞肺癌

Ziogas, Dimitrios C; Tsiara, Anna; Tsironis, Georgios; Lykka, Maria; Liontos, Michalis; Bamias, Aristotelis; Dimopoulos, Meletios-Athanasios

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer

trebananib (AMG386) 的概况及其在卵巢癌治疗中的潜力

Liontos, Michalis; Lykka, Maria; Dimopoulos, Meletios-Athanasios; Bamias, Aristotle